Shopping Cart
- Remove All
Your shopping cart is currently empty
Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits antitumor activity by blocking CD47 and binding primarily to the N-terminal pyroglutamate of CD47. It can be used in combination with other compounds for the treatment of recurrent myeloma.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $172 | In Stock | |
| 5 mg | $492 | In Stock | |
| 10 mg | $782 | In Stock | |
| 25 mg | $1,170 | Backorder | |
| 50 mg | $1,580 | Backorder |
| Description | Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits antitumor activity by blocking CD47 and binding primarily to the N-terminal pyroglutamate of CD47. It can be used in combination with other compounds for the treatment of recurrent myeloma. |
| Synonyms | Magrolimab (anti-CD47), Hu5F9-G4 |
| Cas No. | 2169232-81-7 |
| Relative Density. | no data available |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.